Biogenera Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 10

Biogenera General Information

Description

Developer of biotechnology pharmaceutical therapies intended to research and develop DNA-based medicines for the treatment of serious diseases. The company offers DNA-based biotechnological medicines, gene-specific molecules, MyGenera platform, drug development processes, and preclinical research activities, enabling pharmaceutical researchers and healthcare organizations access to tools for developing patient-specific treatments targeting mutated genes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via dell'Artigianato 2
  • Ozzano dell'Emilia
  • 40064 Bologna
  • Italy
+39 051
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Via dell'Artigianato 2
  • Ozzano dell'Emilia
  • 40064 Bologna
  • Italy
+39 051

Biogenera Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biogenera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Accelerator/Incubator 01-Jan-2025 Completed Pre-Clinical Trials
10. Equity Crowdfunding 29-Jun-2024 Completed Pre-Clinical Trials
9. Equity Crowdfunding Completed Pre-Clinical Trials
8. Later Stage VC (Series A) 01-Oct-2021 Completed Pre-Clinical Trials
7. Equity Crowdfunding 25-Jun-2021 Completed Startup
6. Reverse Merger 16-Jul-2020 Cancelled Startup
5. Equity Crowdfunding 21-Oct-2018 Completed Startup
4. Equity Crowdfunding 03-Oct-2017 Completed Startup
3. Seed Round 24-Jun-2015 $2.57M $6.05M Completed Startup
2. Seed Round 01-Jun-2013 $1.5M $3.48M Completed Startup
To view Biogenera’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Biogenera Patents

Biogenera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2013223694-A1 Oligonucleotides for modulating gene expression and uses thereof Active 24-Feb-2012
AU-2013223694-B2 Oligonucleotides for modulating gene expression and uses thereof Active 24-Feb-2012
AU-2018278972-A1 Oligonucleotides for modulating gene expression and uses thereof Inactive 24-Feb-2012
CA-2864060-A1 Oligonucleotides for modulating gene expression and uses thereof Active 24-Feb-2012
EP-2817407-A2 Oligonucleotides for modulating gene expression and uses thereof Active 24-Feb-2012 C12N15/1135
To view Biogenera’s complete patent history, request access »

Biogenera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biogenera Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
INNOVIT (San Francisco) Accelerator/Incubator
Investinit Venture Capital Minority
Sistema Investimenti Venture Capital Minority
Angel (individual) Minority
FocusFuturo Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Biogenera FAQs

  • When was Biogenera founded?

    Biogenera was founded in 2008.

  • Where is Biogenera headquartered?

    Biogenera is headquartered in Bologna, Italy.

  • What is the size of Biogenera?

    Biogenera has 10 total employees.

  • What industry is Biogenera in?

    Biogenera’s primary industry is Drug Discovery.

  • Is Biogenera a private or public company?

    Biogenera is a Private company.

  • What is Biogenera’s current revenue?

    The current revenue for Biogenera is .

  • How much funding has Biogenera raised over time?

    Biogenera has raised $15M.

  • Who are Biogenera’s investors?

    INNOVIT (San Francisco), Investinit, Sistema Investimenti, , and FocusFuturo are 5 of 10 investors who have invested in Biogenera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process